Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
Equals update demonstrates growth potential of corporate market

AJ Bell is an easy to use, award-winning platform Open an account
We've accounts to suit every investing need, and free guides and special offers to help you get the most from them.
You can get a few handy suggestions, or even get our experts to do the hard work for you – by picking one of our simple investment ideas.
All the resources you need to choose your shares, from market data to the latest investment news and analysis.
Funds offer an easier way to build your portfolio – we’ve got everything you need to choose the right one.
Starting to save for a pension, approaching retirement, or after an explainer on pension jargon? We can help.
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
Equals (EQLS:AIM) 47.8p
Gain to date: 11.2%
Original entry point: Buy at 43p, 29 April 2021
Global payments group Equals (EQLS:AIM) posted a strong first half trading update on 8 July, showing revenue growth of more than 20% compared with the first six months of last year even without a meaningful recovery in travel-related foreign exchange revenues.
In fact, travel-related activity made up less than 5% of group turnover compared with more than 30% historically, which not only shows how far the firm has diversified since the onset of Covid but also the potential upside to revenues when normal overseas travel is back on the agenda.
The majority of the growth is coming from the Equals Money suite of products aimed at corporate customers, with the firm seeing record levels of international payment transactions and record activity on its Spend platform in the second quarter.
Having turned cash flow positive at the end of last year, the firm now boasts £9.2 million of cash on hand and is claiming £1.3 million in R&D credits for last year.
Encouragingly, the shares have pushed on despite uncertainty over the 22.4% stake held by activist investor Crystal Amber (CRS:AIM), which itself has become the target of an activist who aims to veto the fund’s continuation vote in November, potentially triggering a break-up and the liquidation of its holdings.
SHARES SAYS: Keep buying.
These articles are provided by Shares magazine which is published by AJ Bell Media, a part of AJ Bell. Shares is not written by AJ Bell.
Shares is provided for your general information and use and is not a personal recommendation to invest. It is not intended to be relied upon by you in making or not making any investment decisions. The investments referred to in these articles will not be suitable for all investors. If in doubt please seek appropriate independent financial advice.
Investors acting on the information in these articles do so at their own risk and AJ Bell Media and its staff do not accept liability for losses suffered by investors as a result of their investment decisions.
The value of your investments can go down as well as up and you may get back less than you originally invested. We don't offer advice, so it's important you understand the risks, if you're unsure please consult a suitably qualified financial adviser. Tax treatment depends on your individual circumstances and rules may change. Past performance is not a guide to future performance and some investments need to be held for the long term.
Our website uses cookies to give you a better browsing experience.
You can choose to accept all cookies, or control which we use by clicking 'Manage cookies'. To learn more, read our cookie policy.